The novel PDE10A inhibitor CPL'36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

Under a Republican-led budget bill, US doctors and dentists would no longer be able to count residency years toward the ...

These students say maintaining a simple hobby isn’t a distraction — it’s a mental health weapon that helps them maintain ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

Experts call for stronger regulation of digital food marketing to counter the increasing risk for obesity and teens’ ...

The new infusion for maple syrup urine disease is for patients who cannot have an oral or enteral branched-chain amino ...

A systematic review and meta-analysis found that ultrasound had a high diagnostic accuracy for testicular torsion, with ...

The autologous immunotherapy consists of the patient’s own T cells engineered to express a chimeric antigen receptor that ...

In a new study, mixed reality exposure therapy shows no advantage over self-guided therapy in alleviating symptoms of OCD, ...

An intervention combining education with mobile health support in the emergency department leads to greater blood pressure ...

The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...

Only 39.3% of US clinicians who treat youths screen for substance use disorders in line with recommended guidelines, a recent ...